Cabrellis Pharmaceuticals
Cabrellis Pharmaceuticals Corporation develops therapies for the treatment of cancer.
Business Model:
Revenue: $0
Employees: 11-50
Rankings
Industries / Tags:
Detailed Cabrellis Pharmaceuticals Information
Cabrellis Pharmaceuticals was acquired by
Pharmion.
The acquisition happend on 2006-11-15.
Details of the transaction were not public
Acquirer
Geographic Data
Address:
City: San Diego
State: California
Zip:
Country: United States
Financial Info
Stage:
series a
Raised Last:
$28M
Raised Total:$28M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Cabrellis Pharmaceuticals Corporation, a specialty pharmaceutical company developing therapies for the treatment of cancer. Cabrellis plans to initiate three separate clinical trials in small cell lung cancer (SCLC) in 2006. The first trial, designed to assess the safety and efficacy of Calsed(TM) in reference to topotecan in the second-line treatment of patients with SCLC who previously responded to platinum-based chemotherapy, is currently underway at multiple clinical trial sites in the United States.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 8/2006 | Series A | 8 | $27.5M |
Domain Associates Forward Ventures Lilly Ventures Novo Holdings ProQuest Investments RBC Venture Partners RiverVest SR One Domain Associates Forward Ventures Lilly Ventures Novo Holdings ProQuest Investments RBC Venture Partners RiverVest SR One |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
